Huntington Disease Ethics - Elliot Flashcards
What is pre-symptomatic genetic testing?
- Test for variants causing or associated with diseases or disorders known to be inherited in the family, often with adult-onset symptoms.
What is the purpose of pre-symptomatic genetic testing?
Accurate risk assessment
What is the value of pre-symptomatic genetic testing?
Depends on effectiveness of prevention (if possible), management, and treatment.
***Must be tailored to individual preferences and family needs/experiences.
What are the implications of pre-symptomatic genetic testing in HD?
- Decide
- <5%, due to emotional/confidentiality risks
- Referred to HD site/lab
- Multi-disciplinary counseling
- Informed consent
- Test
- Multi-disciplinary counseling
- whether +/-
- Counseling at least a month before test, and then over years in follow-up.
What is the reality/consequences of pre-symptomatic genetic testing in HD?
- 40+ repeats in the Huntington gene confers a 100% chance of HD
- No cure
- No treatment to delay, slow, stop, or reverse the disease
- The choice to undergo predictive testing is a matter of personal choice with significant psycho-social implications
- Must have pre- and post-test counseling
What are two testing options for pre-implantation or prenatal stages?
- IVF - when affected parent desires non-affected child
- Exclusion test - when parent does not want to know personally, but wants to assure/know if offspring at high risk for disease
What are the general ethical issues in pre-implantation & prenatal testing for HD?
-
Beneficence
- knowledge is power
- planning for life
-
Non-maleficence
- do no harm
- emotional, psychological, family, social harm
- privacy/confidentiality/access to results
-
Autonomy
- informed consent process
-
Justice
- Is it ethical to test for diseases in which there is no cure?
- $1000 cost for test & counseling
What are the ethical dimensions of genetic testing, especially in relation to the Human Genome Project?
- ELSI
- Ethical
- Legal
- Social Implications
- Issues:
- use of information
- privacy and confidentiality
- stigmatization
- reproductive issues
- clinical concerns
- uncertainties of testing and therapies
- commercialization
- patenting
- ETC.